Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H29FN2O4 |
Molecular Weight | 428.4965 |
Optical Activity | ( - ) |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=CC=C1OCCCN2CCC(CC2)C3=NOC4=CC(F)=CC=C34)[C@H](C)O
InChI
InChIKey=SBKZGLWZGZQVHA-INIZCTEOSA-N
InChI=1S/C24H29FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-17,28H,3,8-13H2,1-2H3/t16-/m0/s1
Molecular Formula | C24H29FN2O4 |
Molecular Weight | 428.4965 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.google.ch/patents/US7977356
Sources: https://www.google.ch/patents/US7977356
P-88-8991, (-)- is a metabolite of Iloperidone. It has functional affinity for noradrenergic, dopaminergic and serotoninergic receptors. Humans produce only one enantiomer stereospecifically following administration of Iloperidone. Preclinical studies revealed that P-88-8991, (-)- might be useful for the treatment of psychotic disorders such as schizophrenia and bipolar disorders.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094251 Sources: https://www.google.ch/patents/US7977356 |
8.9 null [pKi] | ||
Target ID: CHEMBL1916 Sources: https://www.google.ch/patents/US7977356 |
7.8 null [pKi] | ||
Target ID: CHEMBL322 Sources: https://www.google.ch/patents/US7977356 |
8.9 null [pKi] | ||
Target ID: CHEMBL3372 Sources: https://www.google.ch/patents/US7977356 |
8.1 null [pKi] | ||
Target ID: CHEMBL217 Sources: https://www.google.ch/patents/US7977356 |
7.4 null [pKi] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.google.ch/patents/US7977356
Curator's Comment: Human: 1 to about 300 mg/kg in divided doses up to four times a day
Rat: 0.01 to about 10 mg/kg
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:45:52 GMT 2023
by
admin
on
Sat Dec 16 01:45:52 GMT 2023
|
Record UNII |
7SV1ZOG031
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7SV1ZOG031
Created by
admin on Sat Dec 16 01:45:52 GMT 2023 , Edited by admin on Sat Dec 16 01:45:52 GMT 2023
|
PRIMARY | |||
|
10365268
Created by
admin on Sat Dec 16 01:45:52 GMT 2023 , Edited by admin on Sat Dec 16 01:45:52 GMT 2023
|
PRIMARY | |||
|
501373-88-2
Created by
admin on Sat Dec 16 01:45:52 GMT 2023 , Edited by admin on Sat Dec 16 01:45:52 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|